Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 437, pseudogene (RNU6-437P)
- Target
- RNU6-437P
- Molecular classification
- Other, Pseudogene, Small nuclear RNA (snRNA)-derived pseudogene
01
Overview
RNU6-437P (RNA, U6 small nuclear 437, pseudogene) is a processed *pseudogene* that represents a non-functional copy derived from the gene encoding U6 small nuclear RNA (snRNA). Unlike the functional U6 snRNA, which participates in the catalytic core of the spliceosome and is essential for pre-mRNA splicing in eukaryotic nuclei, RNU6-437P does not encode a functional RNA or protein and is classified as genomic "junk" or evolutionary remnant. Multiple U6-derived pseudogenes exist in the human genome, likely as a result of retrotransposition events. These sequences are generally considered transcriptionally inert and do not contribute to cellular function. There is currently no information suggesting that RNU6-437P is involved in human disease or is a viable therapeutic target.
- Other names
- RNU6-437PRNA, U6 small nuclear 437, pseudogene
02
Mechanism of action
None; there are no known drugs or small molecules that target this pseudogene.
03
Biological functions
None directly assigned to RNU6-437P; as a *pseudogene* of U6 snRNA, it does not have a known functional role in gene regulation or cellular processes.Pseudogenes in general may act as *competitive endogenous RNAs* (ceRNAs) or influence gene regulation via RNA networks, but specific functions for RNU6-437P have not been demonstrated.The parental U6 snRNA is involved in spliceosomal intron removal, but the pseudogene does not encode a functional RNA or protein.
04
Disease associations
No established disease association for RNU6-437P.In general, pseudogenes may act as decoys or modulators within gene regulatory networks, but there are no published associations of RNU6-437P with human disease.
05
Safety considerations
There are no known safety concerns or therapeutic challenges associated with RNU6-437P, since it is not a functional gene or target.
Beyond the preview
Go deeper on RNA, U6 small nuclear 437, pseudogene (RNU6-437P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 437, pseudogene (RNU6-437P).